Neurology News

In-depth MRI techniques and analysis in multiple sclerosis (Webinar)

21 Jan 2021

Free-of-charge Digital Course on In-depth MRI techniques and analysis in multiple sclerosis by Scientific Seminars.

Hematopoietic stem cell transplants may provide long-term benefit for people with MS

20 Jan 2021

A new study shows that intense immunosuppression followed by a hematopoietic stem cell transplant may prevent disability associated with multiple sclerosis (MS) from getting worse in 71% of people with relapsing-remitting MS for up to 10 years after the treatment. 

A plea for equitable global access to COVID‐19 diagnostics, vaccination and therapy: the NeuroCOVID‐19 task Force of the EAN

18 Jan 2021

COVID‐19 continues to challenge health and care systems around the globe. The pandemic has disrupted acute neurology services and routine patient care and has impacted the clinical course in patients with chronic neurologic disease. COVID‐19 appears to have exposed inequalities of societies and healthcare systems and had disproportionate impact on already vulnerable communities. 

Medical oddity ushers in discovery of unheard-of 'immunity gene' mutations — and a better way to screen them

18 Jan 2021

An infant’s odd case of encephalitis, not typically found in children, has led Japanese researchers to discover never-before-seen genetic mutations and a more accurate technique to examine the IRAK4 gene responsible for innate immunity. Their work has been published in the Journal of Clinical Immunology.

Joint International Headache Congress 2021

15 Jan 2021

Two of the most important headache societies, the International Headache Society (IHS) and the European Headache Federation (EHF) will unite for a joint International Headache Congress 2021, scheduled from 8–12 September in Berlin, Germany.

Faulty metabolism of Parkinson’s medication in the brain linked to severe side effects

7 Jan 2021

Until now, the reason why the drug levodopa (L-Dopa), which reduces the motor symptoms of Parkinson’s disease, declines in efficacy after a few years’ use has been unknown. A side effect that then often occur is involuntary movements. A Swedish–French collaboration, led from Uppsala University, has now been able to connect the problems with defective metabolism of L-Dopa in the brain.

NIH study uncovers blood vessel damage and inflammation in COVID-19 patients’ brains but no infection

30 Dec 2020

Results from a study of 19 deceased patients suggests brain damage is a byproduct of a patient’s illness.

Scientists solve 100-year-old cerebral malaria mystery using neuroimaging techniques

16 Dec 2020

Research reveals biggest cause of malaria deaths in adults is brought about through oxygen-deprivation

No association between COVID-19 and Guillain-Barré syndrome

13 Dec 2020

Neuroscientists at UCL have found no significant association between COVID-19 and the potentially paralysing and sometimes fatal neurological condition Guillain-Barré syndrome. Researchers say the findings, published in the journal Brain, along with a linked scientific commentary by UCL and other international experts, should provide the public with reassurance, as the UK’s national coronavirus vaccination programme is rolled out.

New biomarker candidate for amyotrophic lateral sclerosis

8 Dec 2020

A diagnostic tool for the rare neurological disease amyotrophic lateral sclerosis (ALS) has been developed using infrared analyses of neuronal proteins to provide information on molecular changes in patients with ALS.
1